Entries tagged "GlaxoSmithKline"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "GlaxoSmithKline."

12 result(s) displayed (1 - 12 of 14)

GSK shops Lucozade, Ribena brands

British biotech's noncore assets could fetch more than $1.5 billion, analysts say. Continue reading

Posted on April 25, 2013 9:45 AM

Slow drug sales could mean buyout of HGSI

GlaxoSmithKline, its partner on a lupus treatment, is considered a potential acquirer. Continue reading

Posted on August 26, 2011 2:17 PM

Deep cleansing treatment

As Pfizer prepares for another digestive challenge in the form of Wyeth, it is trying to unload some compounds it already has. Continue reading

Posted on June 5, 2009 11:54 AM

Blackstone's there for Stiefel

Willkie Farr's Gregory Astrachan and others advised Stiefel on its sale to GSK. Continue reading

Posted on May 1, 2009 10:22 AM

Paging Dr. Scholl

The consumer-products subplot in the pharmaceutical megamergers. Continue reading

Posted on March 20, 2009 1:59 PM

The big trial

From VC to licensing, Exelixis has done every kind of deal to keep itself afloat, except one. Is an acquisition next? Continue reading

Posted on March 6, 2009 11:29 AM

Where dealmaking is healthy

Veteran healthcare dealmakers are moving to smaller firms, including Samantha Miller, who joined Jennerex Biotherapeutics. Continue reading

Posted on January 23, 2009 12:43 PM

They need a new drug

Expect Big Pharma to go shopping in biotechland, but with an eye for fire sales. Continue reading

Posted on January 9, 2009 2:10 PM

This won't hurt a bit

An examination of U.S. healthcare under the Obama administration. Continue reading

Posted on November 14, 2008 3:15 PM

Bridge over troubled waters

California's stem cell institute has money to lend to biotech startups and, it hopes, lure VCs to the table. Continue reading

Posted on October 31, 2008 3:52 PM

Diagnosis: Investment opportunity

VCs have poured billions into diabetes-related startups, and the trend isn't likely to slow. Continue reading

Posted on October 17, 2008 3:20 PM

A seller's market

Universities are getting in on pharma royalty deals. Continue reading

Posted on September 5, 2008 1:43 PM

Movable Type search results powered by Fast Search